London School of Hygiene and Tropical Medicine, London, UK.
Malawi-Liverpool Wellcome Trust Clinical Research Programme, P.O. Box 30096, Chichiri, Blantyre, Malawi.
BMC Med Ethics. 2023 Feb 10;24(1):8. doi: 10.1186/s12910-023-00889-x.
Medical researchers in resource-constrained settings must make difficult moral decisions about the provision of ancillary care to participants where additional healthcare needs fall outside the scope of the research and are not provided for by the local healthcare system. We examined research stakeholder perceptions and experiences of ancillary care in biomedical research projects in Malawi.
We conducted 45 qualitative in-depth interviews with key research stakeholders: researchers, health officials, research ethics committee members, research participants and grants officers from international research funding organisations. Thematic analysis was used to analyse and interpret the findings.
All stakeholders perceived the provision of ancillary care to have potential health benefits to study participants in biomedical research. However, they also had concerns, particularly related to the absence of guidance to support it. Some suggested that consideration for ancillary care provision could be possible on a case-by-case basis but that most of the support from research projects should be directed towards strengthening the public health system, emphasising public good above individual or personal benefits. Some researchers and ethics committee members raised concerns about potential tensions in terms of funding, for example balancing study demands with addressing participants' additional health needs.
Our findings highlight the complexities and gaps in the guidance around the provision of ancillary care in Malawi and other resource-constrained settings more generally. To promote the provision of ancillary care, we recommend that national and international guidelines for research ethics include specific recommendations for resource-constrained settings and specific types of research.
资源有限环境下的医学研究人员必须在为参与者提供辅助医疗方面做出艰难的道德决策,因为这些额外的医疗需求超出了研究范围,并且不受当地医疗系统的保障。我们调查了在马拉维的生物医学研究项目中研究利益相关者对辅助医疗的看法和经验。
我们对主要研究利益相关者进行了 45 次深入的定性访谈:研究人员、卫生官员、研究伦理委员会成员、研究参与者和国际研究资助组织的拨款官员。使用主题分析来分析和解释研究结果。
所有利益相关者都认为在生物医学研究中为参与者提供辅助医疗有潜在的健康益处。然而,他们也有一些担忧,特别是缺乏支持提供辅助医疗的指导。一些人认为,可以根据具体情况考虑提供辅助医疗,但大多数来自研究项目的支持应致力于加强公共卫生系统,强调公共利益高于个人或个人利益。一些研究人员和伦理委员会成员提出了有关资金方面的潜在紧张局势的担忧,例如平衡研究需求与解决参与者额外的健康需求。
我们的研究结果突出了在马拉维和其他资源有限环境中提供辅助医疗的指导方面的复杂性和差距。为了促进辅助医疗的提供,我们建议为研究伦理制定国家和国际准则,包括针对资源有限环境和特定类型研究的具体建议。